We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App





Isothermal Amplification Based COVID-19 Test System Could Detect Any Coronavirus Variant

By LabMedica International staff writers
Posted on 29 Dec 2021

Researchers have developed a strategy to create a cheap and rapid COVID-19 test based on isothermal amplification that will make it possible to create universal test systems for any of the COVID-19 variants. More...

The strategy developed by researchers at the HSE University (Moscow, Russia) will decrease the cost of COVID-19 tests considerably and speed up the process, since no specially trained professionals or expensive equipment will be needed. There are several options for systems that detect traces of SARS-CoV-2 in human blood or secretion samples. They usually detect either scraps of COVID-19’s pathogen RNA using polymerase chain reaction (PCR) and its analogues, or antibodies to COVID-19. Usually, quite a lot of time is required for such a test, from 30 minutes to several hours, which is why researchers are looking for new, faster methods to detect antibodies or COVID infection.

The Russian researchers have been working on another alternative to PCR tests that is based on so-called loop-mediated isothermal amplification (LAMP). This testing approach allows for multiplication of certain DNA or RNA fragments from bio samples with the use of special markers and ferments of extremophilic bacteria that reside in hot springs. The key advantage of LAMP over PCR is that all reactions can be made at the same temperature. This simplifies and speeds up the process. But these systems are much more complicated to develop and have a few drawbacks, which has previously limited their use in COVID-19 test systems. The new strategy developed by the researchers will help overcome these drawbacks and give healthcare professionals an opportunity to use LAMP testing to detect traces of any COVID variants in samples of mucus and blood without preliminary processing in a laboratory.

Related Links:
HSE University 


Platinum Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Flock Tipped Applicator
HydraFlock 6" Sterile Large Flock Swab w/Polystyrene Handle, 80mm Breakpoint
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.